WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2015122570) MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO VIBRIO VULNIFICUS RTXA-1 PROTEIN AND USE THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2015/122570    International Application No.:    PCT/KR2014/003659
Publication Date: 20.08.2015 International Filing Date: 25.04.2014
IPC:
C12N 5/20 (2006.01), C07K 16/12 (2006.01), A61K 39/40 (2006.01)
Applicants: INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY [KR/KR]; 567, Baekje-daero, Deokjin-gu Jeonju-si Jeollabuk-do 561-756 (KR)
Inventors: CHUNG, Kyung Min; (KR).
RHEE, Joon Haeng; (KR).
WOO, Hye Ryun; (KR).
LEE, Tae Hee; (KR)
Priority Data:
10-2014-0016693 13.02.2014 KR
Title (EN) MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO VIBRIO VULNIFICUS RTXA-1 PROTEIN AND USE THEREOF
(FR) ANTICORPS MONOCONAL SE LIANT DE MANIÈRE SPÉCIFIQUE À LA PROTÉINE RTXA-1 DE VIBRIO VULNIFICUS ET UTILISATION DE CE DERNIER
(KO) 비브리오 패혈증균 알티엑스에이-1 단백질에 특이적으로 결합하는 단일클론 항체 및 이의 용도
Abstract: front page image
(EN)The present invention relates to a monoclonal antibody specifically binding to Vibrio vulnificus RtxA-1 protein and a use thereof. More specifically, the monoclonal antibody has high sensitivity, specificity, and susceptibility through high-affinity specific binding capacity to Vibrio vulnificus, can be favorably used to prevent and treat diseases caused by Vibrio vulnificus and related infection, and has an excellent vaccine effect, and thus can be used as an agent for preventing and/or treating Vibrio vulnificus sepsis.
(FR)La présente invention concerne un anticorps monoclonal se liant de manière spécifique à la protéine RtxA-1 de Vibrio vulnificus et une utilisation de celui-ci. Plus spécifiquement, l'anticorps monoclonal présente des caractéristiques élevées de sensibilité, de spécificité et de réactivité via une capacité de liaison spécifique d’affinité élevée à Vibrio vulnificus, peut être favorablement utilisé dans le traitement prophylactique et thérapeutique des maladies provoquées par Vibrio vulnificus et d'infections apparentées, et présente un excellent effet de vaccin, et peut donc être utilisé en tant qu'agent dans le traitement prophylactique et/ou thérapeutique d'une septicémie à Vibrio vulnificus.
(KO)본 발명은 비브리오 패혈증균 알티엑스에이-1(RtxA1)에 특이적으로 결합하는 단일클론항체 및 이의 용도에 관한 것으로, 보다 상세하게는 비브리오 패혈증균에 대한 고친화도의 특이적 결합능력으로 높은 감수성, 특이성 및 민감도를 가지며, 비브리오 패혈증균과 그에 관련된 감염에 의해서 유발되는 질병의 예방 및 치료에 유용하게 이용될 수 있으며, 우수한 백신효과를 가짐으로써 비브리오 패혈증 예방제 및/또는 치료제로 사용될 수 있다.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Korean (KO)
Filing Language: Korean (KO)